GlucoTrack, Inc. Common Stock

GCTKNASDAQUSD
0.53 USD
0.00 (0.19%)🟢LIVE (AS OF 02:24 PM EDT)
🟢Market: OPEN

GCTK is currently priced at $0.53. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (1984.3%) and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jul 15, 2026.

Open?$0.48
High?$0.58
Low?$0.45
Prev. Close?$0.53
Volume?2.9M
Avg. Volume?4.6M
VWAP?$0.51
Rel. Volume?0.62x
Bid / Ask
Bid?$0.48 × 2.0K
Ask?$0.57 × 4.2K
Spread?$0.09
Midpoint?$0.52
Valuation & Ratios
Market Cap?3.3M
Shares Out?6.3M
Float?6.2M
Float %?99.6%
P/E Ratio?N/A
P/B Ratio?-3.90
EPS?-$2.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
Employees
15
Market Cap
3.3M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2000-12-10
Address
301 RT 17 NORTH
RUTHERFORD, NJ 07070
Phone: 972 (8) 675-7878
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
66
Piotroski F-Score?0/9Weak
Altman Z-Score?-62.74Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.19%Elevated
Short Interest?510.3K
Days to Cover?2.2
Free Float6.2M
Avg Daily Volume236.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.85Weak
Quick Ratio?0.85Weak
Cash Ratio?0.79Adequate
Debt/Equity?-0.27Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
S&P
97
-3.90CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
Peers
50
S&P
97
1,984.3%STRONG
ROA?
S&P
3
-387.7%WEAK
Cash Flow & Enterprise
FCF?$-16436000
Enterprise Value?$-379582
Fundamentals ratios updated end of day